As the results of our study also demonstrated, most clinical studies failed to show any association of circulating visfatin with fasting glucose, insulin levels, HOMA-IR (5,8,9,26,27,28), and insulin sensitivity (23,29) in either healthy subjects, obese subjects or diabetics. Here, INS is linked to diabetes mellitus.